Concepedia
Statistics
Publications
12
Citations
1.8K
H-Index
Active since
1978
Affiliations
University of Colorado Denver(Current)
The University of Texas at San Antonio Health Science Center
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
Emory University
Michael Glodé is an author at University of Colorado Denver specializing in medicine, oncology, and prostate cancer.
Publications per year
1978–2022
Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma
Elise A. Olsen, Madeleine Duvic, Arthur E. Frankel et al. · Journal of Clinical Oncology · 2001 · 610 citations
Medicine, Oncology, Pharmacology +17
A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.
William D. Ensminger, A. Rosowsky, Vic Raso et al. · PubMed · 1978 · 524 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
A study of high‐dose oral silybin‐phytosome followed by prostatectomy in patients with localized prostate cancer
Thomas W. Flaig, Michael Glodé, Daniel L. Gustafson et al. · The Prostate · 2010 · 191 citations
Medicine, Oncology, Pharmacology +13
Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control
Michelle A. Stinauer, Brian D. Kavanagh, Tracey E. Schefter et al. · Radiation Oncology · 2011 · 158 citations · Full text
Medicine, Oncology, Radiation Oncology +17
Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma.
Ulka N. Vaishampayan, Michael Glodé, Wei Du et al. · PubMed · 2000 · 138 citations
Medicine, Pharmacology, Pharmacotherapy +17
1–5 of 12